share_log

Baird Maintains Outperform on Instil Bio, Lowers Price Target to $31

Benzinga Real-time News ·  Sep 6, 2022 09:08

Baird analyst Jack Allen maintains Instil Bio (NASDAQ:TIL) with a Outperform and lowers the price target from $34 to $31.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment